Want to see IN:FAIRCHEMOR full AI Analyst Report?
Top Page
Fairchem Organics Ltd
(FAIRCHEMOR)
Select Model
Select Model
Rating:52Neutral
Price Target:
₹699.00
▼(-8.76% Downside)
Action:Reiterated
Date:10/14/26
The score is held back primarily by deteriorating profitability and returns (weak margins and ROE), despite a FY2026 cash-flow rebound and manageable leverage. Technicals are supportive (price above key DMAs and positive MACD) but look overbought, and valuation is mixed—high P/E is a headwind while the very high dividend yield provides partial support.
Positive Factors
Manageable leverage
Moderate leverage gives Fairchem Organics financial flexibility to continue operations and fund selected growth without excessive balance-sheet strain. Although debt has risen, the current ratio remains manageable and provides a more durable foundation than a highly leveraged capital structure.
Negative Factors
Material margin compression
The sharp decline in net margin indicates that recent revenue is producing substantially less profit than in prior years. Continued pressure from costs, pricing or product mix would reduce reinvestment capacity and make earnings more vulnerable even if the company remains profitable.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable leverage
Moderate leverage gives Fairchem Organics financial flexibility to continue operations and fund selected growth without excessive balance-sheet strain. Although debt has risen, the current ratio remains manageable and provides a more durable foundation than a highly leveraged capital structure.
Read all positive factors
Fairchem Organics Ltd (FAIRCHEMOR) vs. iShares MSCI India ETF (INDA)
Market Cap
₹8.72B
Dividend Yield0.15%
Average Volume (3M)5.10K
Price to Earnings (P/E)36.7
Beta (1Y)0.18
Revenue Growth17.44%
EPS Growth304.08%
CountryIN
Employees212
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)18.80
Shares Outstanding12,595,902
10 Day Avg. Volume5,543
30 Day Avg. Volume5,104
Financial Highlights & Ratios
PEG Ratio-1.36
Price to Book (P/B)2.13
Price to Sales (P/S)1.22
P/FCF Ratio24.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Fairchem Organics Ltd Business Overview & Revenue Model
Company Description
Fairchem Organics Limited, headquartered in Ahmedabad, India, was founded in 2019. This company specializes in the manufacturing and worldwide sale of sophisticated oleochemicals and key nutraceutical components. Its market reach extends across In...
Fairchem Organics Ltd Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
63
Positive
Cash Flow
52
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.60B | 4.60B | 5.38B | 6.21B | 6.47B | 6.42B |
| Gross Profit | 642.92M | 355.37M | 666.52M | 1.54B | 1.56B | 1.78B |
| EBITDA | 446.72M | 220.40M | 441.21M | 681.10M | 729.68M | 1.05B |
| Net Income | 237.76M | 55.41M | 219.74M | 405.00M | 435.01M | 679.06M |
Balance Sheet | ||||||
| Total Assets | 3.98B | 3.91B | 4.02B | 3.34B | 3.42B | 3.24B |
| Cash, Cash Equivalents and Short-Term Investments | 14.24M | 12.26M | 12.86M | 84.00K | 838.00K | 83.00K |
| Total Debt | 702.35M | 837.82M | 630.32M | 73.18M | 501.68M | 620.30M |
| Total Liabilities | 1.17B | 1.28B | 997.98M | 443.77M | 831.48M | 919.26M |
| Stockholders Equity | 2.82B | 2.63B | 3.02B | 2.90B | 2.59B | 2.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 229.13M | -464.87M | 563.52M | 348.89M | 58.91M |
| Operating Cash Flow | 0.00 | 382.54M | -203.78M | 744.80M | 496.15M | 404.85M |
| Investing Cash Flow | 0.00 | -140.95M | -255.71M | -176.25M | -144.92M | -341.84M |
| Financing Cash Flow | 0.00 | -241.53M | 459.49M | -568.55M | -351.24M | -63.19M |
Fairchem Organics Ltd Technical Analysis
Neutral
766.10
Price Trends
683.32
Positive
688.00
Positive
641.38
Positive
Market Momentum
14.93
Positive
44.26
Neutral
42.36
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:FAIRCHEMOR, the sentiment is Neutral. The current price of 766.1 is above the 20-day moving average (MA) of 725.62, above the 50-day MA of 683.32, and above the 200-day MA of 641.38, indicating a neutral trend. The MACD of 14.93 indicates Positive momentum. The RSI at 44.26 is Neutral, neither overbought nor oversold. The STOCH value of 42.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:FAIRCHEMOR.
Fairchem Organics Ltd Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹84.20B | 37.30 | ― | 0.61% | 5.11% | 20.64% | |
62 Neutral | ₹158.90B | 20.65 | ― | 0.56% | 18.15% | 42.38% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | ₹100.41B | 32.36 | ― | 0.79% | 10.96% | 11.16% | |
52 Neutral | ₹8.72B | 36.72 | ― | 0.15% | 17.44% | 304.08% | |
50 Neutral | ₹43.58B | 34.62 | ― | 0.19% | 5.47% | 24.88% | |
47 Neutral | ₹158.16B | 29.74 | ― | 0.23% | 27.05% | 123.98% |
* General Sector Average
IN:FAIRCHEMOR
Fairchem Organics Ltd
692.30
-54.98
-7.36%
IN:AARTIIND
AARTI Industries Ltd
436.00
50.77
13.18%
IN:ALKYLAMINE
Alkyl Amines Chemicals Limited
1,646.25
-246.47
-13.02%
IN:ATUL
Atul Limited
5,397.20
-464.56
-7.93%
IN:JUBLINGREA
Jubilant Ingrevia Ltd.
630.40
-54.69
-7.98%
IN:LXCHEM
Laxmi Organic Industries Ltd.
156.80
-46.30
-22.80%
Fairchem Organics Ltd Corporate Events
Fairchem Organics Confirms Full Demat Compliance Under SEBI Rules
Oct 7, 2026
Fairchem Organics Ltd has reported to the NSE and BSE that it has obtained the required confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The fil...
Fairchem Organics Publishes Q1 FY27 Unaudited Results Extract in Financial Dailies
Jul 28, 2026
Fairchem Organics Ltd has notified the stock exchanges that its Board of Directors approved the unaudited financial results for the quarter ended June 30, 2026, at a meeting held on July 27, 2026. In line with regulatory requirements, an extract o...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.